Skip to main content
. 2017 Dec 9;9(1):706–717. doi: 10.18632/oncotarget.23091

Figure 8. Dactolisib inhibits tumor growth in vivo and prolongs survival of orthotopic glioblastoma-bearing rats.

Figure 8

(A) Axial 3D fast spoiled gradient-echo images. Tumor volumes were significantly different among 3 groups on days 10 and 14. (B) Kaplan–Meier method was used to assess animal survival time. The survival time of rats in the RT+TMZ+dactolisib group was significantly longer than other groups.